3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Neuroleptic Malignant Syndrome

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Neuroleptic Malignant Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bauer, R; Dorndorf, W; Franz, M; Gallhofer, B; Jauss, M; Klett, R; Krack, P	1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Neuroleptic Malignant Syndrome

Article	Year
Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:6 Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benperidol; Benzamides; Dopamine Antagonists; Frontal Lobe; Haloperidol; Humans; Iodine Radioisotopes; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	1996

Article

Year

Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.

Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:6

Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benperidol; Benzamides; Dopamine Antagonists; Frontal Lobe; Haloperidol; Humans; Iodine Radioisotopes; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1996